McCluskey A - Search Results

1

The first two cantharidin analogues displaying PP1 selectivity.

McCluskey A, Keane MA, Walkom CC, Bowyer MC, Sim AT, Young DJ, Sakoff JA. McCluskey A, et al. Bioorg Med Chem Lett. 2002 Feb 11;12(3):391-3. doi: 10.1016/s0960-894x(01)00777-6. Bioorg Med Chem Lett. 2002. PMID: 11814804

2

Pharmacophore development for corticotropin-releasing hormone: new insights into inhibitor activity.

Keller PA, Bowman M, Dang KH, Garner J, Leach SP, Smith R, McCluskey A. Keller PA, et al. Among authors: mccluskey a. J Med Chem. 1999 Jul 1;42(13):2351-7. doi: 10.1021/jm9900117. J Med Chem. 1999. PMID: 10395475

3

Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity.

McCluskey A, Bowyer MC, Collins E, Sim ATR, Sakoff JA, Baldwin ML. McCluskey A, et al. Bioorg Med Chem Lett. 2000 Aug 7;10(15):1687-90. doi: 10.1016/s0960-894x(00)00323-1. Bioorg Med Chem Lett. 2000. PMID: 10937725

4

Solvent-Mediated Allylation of Carbonyl Compounds with Allylic Stannanes.

Cokley TM, Harvey PJ, Marshall RL, McCluskey A, Young DJ. Cokley TM, et al. Among authors: mccluskey a. J Org Chem. 1997 Apr 4;62(7):1961-1964. doi: 10.1021/jo962332l. J Org Chem. 1997. PMID: 11671496

5

Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.

McCluskey A, Walkom C, Bowyer MC, Ackland SP, Gardiner E, Sakoff JA. McCluskey A, et al. Bioorg Med Chem Lett. 2001 Nov 19;11(22):2941-6. doi: 10.1016/s0960-894x(01)00594-7. Bioorg Med Chem Lett. 2001. PMID: 11677131

6

A highly atom efficient, solvent promoted addition of tetraallylic, tetraallenic, and tetrapropargylic stannanes to carbonyl compounds.

McCluskey A, Muderawan IW, Muntari, Young DJ. McCluskey A, et al. J Org Chem. 2001 Nov 16;66(23):7811-7. doi: 10.1021/jo015904x. J Org Chem. 2001. PMID: 11701040

7

Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.

McCluskey A, Sim AT, Sakoff JA. McCluskey A, et al. J Med Chem. 2002 Mar 14;45(6):1151-75. doi: 10.1021/jm010066k. J Med Chem. 2002. PMID: 11881984 Review. No abstract available.

8

Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues.

Sakoff JA, Ackland SP, Baldwin ML, Keane MA, McCluskey A. Sakoff JA, et al. Among authors: mccluskey a. Invest New Drugs. 2002 Feb;20(1):1-11. doi: 10.1023/a:1014460818734. Invest New Drugs. 2002. PMID: 12003183

9

Small molecule inhibitors of serine/threonine protein phosphatases.

McCluskey A, Sakoff JA. McCluskey A, et al. Mini Rev Med Chem. 2001 May;1(1):43-55. doi: 10.2174/1389557013407205. Mini Rev Med Chem. 2001. PMID: 12369990 Review.

10

The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?

McCluskey A, Ackland SP, Gardiner E, Walkom CC, Sakoff JA. McCluskey A, et al. Anticancer Drug Des. 2001 Dec;16(6):291-303. Anticancer Drug Des. 2001. PMID: 12375882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

356 results

Search Page

Filters